×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:

1800 Total Publications

What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?
Andriuta D1, Moullart V2, Schraen S3, Devendeville A1,4, Meyer ME2, Godefroy O1; Alzheimer’s Disease Neuroimaging.
PMID: 26923012 ; 2016; Journal Journal of Alzheimer's Disease; vol. 51; no. 3; pp. 793-800; AWTYnnPpwAl_G9zjEvfE doi:10.3233/JAD-150829
The effect of the top 20 Alzheimer disease risk genes on gray-matter density and FDG PET brain metabolism
E. Stage, T. Duran, S. L. Risacher, N. Goukasian, T. M. Do, J. D. West, H. Wilhalme, K. Nho, M. Phillips, D. Elashoff, A. J. Saykin and L. G. Apostolova
PMID: 28054028 ; PMCID:28054028 ; 2016; Journal Alzheimers Dement (Amst); vol. 5; pp. 53-66; AWTYmIlBwAl_G9zjEveD doi:10.1016/j.dadm.2016.12.003
ADCOMS: a composite clinical outcome for prodromal Alzheimer’s disease trials
J. Wang, V. Logovinsky, S. B. Hendrix, S. H. Stanworth, C. Perdomo, L. Xu, S. Dhadda, I. Do, M. Rabe, J. Luthman, J. Cummings and A. Satlin
PMID: 27010616 ; PMCID:5013117 ; 2016; Journal J Neurol Neurosurg Psychiatry; vol. 87; no. 9; pp. 993-9; AWTYoUyLdzjauPDbjho9 doi:10.1136/jnnp-2015-312383
Graph-guided joint prediction of class label and clinical scores for the Alzheimer’s disease
Yu G1, Liu Y1,2,3, Shen D4,5
PMID: 26476928 ; PMCID:26476928 ; 2016; Journal Brain Struct Funct; vol. 221; no. 7; pp. 3787-801; AWTYsLzpdzjauPDbjhpY doi:10.1007/s00429-015-1132-6
Multistage Grading of Amnestic Mild Cognitive Impairment: The Associated Brain Gray Matter Volume and Cognitive Behavior Characterization
Yang C1, Sun X2, Tao W1, Li X1, Zhang J1, Jia J2, Chen K3, Zhang Z1
PMID: 28119601 ; PMCID:5222841 ; 2016; Journal Front Aging Neurosci.; vol. 8; pp. 332; AWTYO_KSMOwVf_qbJr6g doi:10.3389/fnagi.2016.00332
Using the Disease State Fingerprint Tool for Differential Diagnosis of Frontotemporal Dementia and Alzheimer's Disease
M. A. Munoz-Ruiz, A. Hall, J. Mattila, J. Koikkalainen, S. K. Herukka, M. Husso, T. Hanninen, R. Vanninen, Y. Liu, M. Hallikainen, J. Lotjonen, A. M. Remes, I. Alafuzoff, H. Soininen and P. Hartikainen
PMID: 27703465 ; PMCID:5040932 ; 2016; Journal Dement Geriatr Cogn Dis Extra; vol. 6; no. 2; pp. 313-329; AWTYO_KSMOwVf_qbJr6i doi:10.1159/000447122
Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer's disease biomarker related cognitive decline?
B. S. Ye, W. W. Lee, J. H. Ham, J. J. Lee, P. H. Lee and Y. H. Sohn
2016; Journal Eur J Neurol; vol. 23; no. 5; pp. 948-57; AWUWFPdnMOwVf_qbJr-W doi:10.1111/ene.12969
L2, p-norm and sample constraint based feature selection and classification for AD diagnosis
M. Zhang, Y. Yang, H. Zhang, F. Shen and D. Zhang
2016; Journal Neurocomputing; vol. 195; pp. 104-111; AWUWFPdnMOwVf_qbJr-Y doi:10.1016/j.neucom.2015.08.111
Spatial Patterns of Longitudinal Gray Matter Change as Predictors of Concurrent Cognitive Decline in Amyloid Positive Healthy Subjects
M. A. Araque Caballero, S. Kloppel, M. Dichgans, M. Ewers and I. Alzheimer's Disease Neuroimaging
2016; Journal J Alzheimers Dis; vol. 55; no. 1; pp. 343-358; AWUWFPdnMOwVf_qbJr-a doi:10.3233/JAD-160327
Staging Alzheimer’s Disease Risk by Sequencing Brain Function and Structure, Cerebrospinal Fluid, and Cognition Biomarkers
G. Chen, H. Shu, G. Chen, D. B. Ward, P. G. Antuono, Z. Zhang and S. Li
2016; Journal Journal of Alzheimer's Disease; vol. 54; no. 3; pp. 983-993; AWUVRazdwAl_G9zjEvhR doi:10.3233/JAD-160537